With the growing adoption of personalized medicine and the increasing availability of large-scale healthcare data, the ability to anticipate clinical outcomes at the individual patient level is becoming a fundamental component of modern medical decision-making. Healthcare systems, payers, and researchers are seeking ways to move beyond generalized treatment guidelines and toward tailored, data-driven approaches. … Continue reading What Is Patient-Level Prediction? Personalizing Risk with Real-World Data
Tag: Data
Label Expansion and the Role of RWD
In the lifecycle of a pharmaceutical product, initial regulatory approval is often just the beginning. A newly authorized drug typically enters the market with a carefully defined label specifying the disease, population, dose, and setting for its use based on data from randomized controlled trials (RCTs). But often label specifications evolve. Real world clinical needs… Continue reading Label Expansion and the Role of RWD
Methodological Challenges in RWE Research in Pediatrics
In the evolving landscape of evidence generation, Real-World Data (RWD) has emerged as a vital source of insights across the product lifecycle. However, when it comes to pediatric populations, the generation of Real-World Evidence (RWE) has its unique challenges, both scientific and structural. Children are not just “small adults”; they represent a highly heterogeneous group… Continue reading Methodological Challenges in RWE Research in Pediatrics
The Potential of RWD in Veterinary Medicine: A New Frontier for Pet Health
In recent years, Real-World Data (RWD) has revolutionized human healthcare, driving better decision-making, drug development, and patient outcomes. Yet, another promising and rapidly evolving area for RWD innovation lies in veterinary medicine. As pets are increasingly becoming cherished family members and demand for advanced veterinary care, RWD offers an unprecedented opportunity to also transform animal… Continue reading The Potential of RWD in Veterinary Medicine: A New Frontier for Pet Health
Methodological Considerations in RWD Studies by Intended Use
The growing acceptance of real-world data (RWD) and real-world evidence (RWE) has expanded the horizon for how we generate insights to support decision-making across the product lifecycle. However, while the value of RWD is increasingly recognized by regulators, payers, and safety bodies, the design and methodological rigor of these studies must be carefully tailored to… Continue reading Methodological Considerations in RWD Studies by Intended Use